美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

基因编辑

330.64

-5.7972-1.72%

涨家数：2

跌家数：4

平家数：- -

市盈率：- -

高：338.92

开：336.43

低：326.04

收：336.39

数据加载中...

蓝鸟生物盘中异动下午盘股价大跌5.07%

Editas Medicine, Inc.盘中异动大幅拉升5.47%

Beam Therapeutics Inc.盘中异动早盘快速拉升5.06%报17.86美元

Intellia Therapeutics, Inc.盘中异动大幅上涨5.26%报7.61美元

Intellia Therapeutics, Inc.盘中异动股价大涨5.03%报7.21美元

Crispr Therapeutics Ag盘中异动早盘股价大跌5.04%报36.99美元

Beam Therapeutics Inc.盘中异动快速下跌5.03%

Intellia Therapeutics, Inc.盘中异动早盘大幅下跌5.16%报6.98美元

Editas Medicine, Inc.盘中异动早盘大幅下挫5.18%

蓝鸟生物股价重挫10.07% 市值跌378.69万美元

BUZZ-青鸟生物因艾尔米德公司未能给出具有约束力的收购要约而下跌

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK4556/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4556","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","market":"US","secType":"PLATE","nameCN":"基因编辑","latestPrice":330.5907,"timestamp":1746127743034,"preClose":336.38788,"halted":0,"volume":7145141,"delay":0,"changeRate":-0.017234,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-5.79718,"latestTime":"05-01 15:29:04 EDT","open":336.43045,"high":338.92038,"low":326.03583,"amount":95611807.181553,"amplitude":0.038303,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1746129600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":1.731375,"peRate":-3.451034,"turnoverRate":0.012175,"increases":2,"decrements":4,"flats":0,"marketCap":6500559016,"floatMarketCap":6240509164},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","high":338.92038,"amplitude":0.038303,"preClose":336.38788,"low":326.03583,"pbRate":"1.731375","latestPrice":330.6418,"volume":7144838,"delay":0,"open":336.43045,"prevYearClose":376.62552,"prevWeekClose":329.3158,"prevMonthClose":336.3879,"prevQuarterClose":297.7814,"fiveDayClose":336.2601,"twentyDayClose":295.6819,"sixtyDayClose":376.4462,"secType":"PLATE","market":"US","turnoverRate":0.012175,"peRate":-3.451034,"marketCap":6500559016,"floatMarketCap":6240509164,"timestamp":1746127738171,"nameCN":"基因编辑"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4556\",,,,undefined,":{"bkCode":"BK4556","up":2,"down":4,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4556\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529319663","title":"蓝鸟生物盘中异动 下午盘股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529319663","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529319663?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 01:46","pubTimestamp":1745257575,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日01时46分，蓝鸟生物股票出现异动，股价快速跳水5.07%。截至发稿，该股报3.93美元/股，成交量3.4246万股，换手率0.35%，振幅4.38%。机构评级方面，在所有5家参与评级的机构中，20%的券商给予买入建议，80%的券商给予持有建议，无券商给予卖出建议。蓝鸟生物股票所在的生物技术行业中，整体跌幅为0.66%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422014615a4615edd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422014615a4615edd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BLUE","BK4578","BK4556"],"gpt_icon":0},{"id":"2529389678","title":"Editas Medicine, Inc.盘中异动 大幅拉升5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529389678","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529389678?lang=zh_cn&edition=fundamental","pubTime":"2025-04-21 22:13","pubTimestamp":1745244825,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日22时13分，Editas Medicine, Inc.股票出现异动，股价急速上涨5.47%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421221345aa2c7440&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421221345aa2c7440&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","EDIT"],"gpt_icon":0},{"id":"2529002118","title":"Beam Therapeutics Inc.盘中异动 早盘快速拉升5.06%报17.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529002118","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529002118?lang=zh_cn&edition=fundamental","pubTime":"2025-04-21 22:09","pubTimestamp":1745244551,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日22时09分，Beam Therapeutics Inc.股票出现波动，股价快速拉升5.06%。截至发稿，该股报17.86美元/股，成交量19.0309万股，换手率0.19%，振幅6.61%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家生物技术公司，致力于基于其专有的碱基编辑技术开发一类新的精准基因药物，为患有严重疾病的患者提供终身治愈方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421220911aa2c7438&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421220911aa2c7438&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4585","BK4139","BK4007","BK4535","BK4505","BK4588","BEAM","BK4611","BK4556"],"gpt_icon":0},{"id":"2529802975","title":"Intellia Therapeutics, Inc.盘中异动 大幅上涨5.26%报7.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529802975","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529802975?lang=zh_cn&edition=fundamental","pubTime":"2025-04-21 21:43","pubTimestamp":1745243018,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日21时43分，Intellia Therapeutics, Inc.股票出现异动，股价快速上涨5.26%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421214339973f752c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421214339973f752c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU1861559042.SGD","LU1861558580.USD","BK4007","NTLA","LENZ","BK4535","BK4139","BK4556","BK4585"],"gpt_icon":0},{"id":"2528778867","title":"Intellia Therapeutics, Inc.盘中异动 股价大涨5.03%报7.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528778867","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528778867?lang=zh_cn&edition=fundamental","pubTime":"2025-04-18 03:36","pubTimestamp":1744918600,"startTime":"0","endTime":"0","summary":"北京时间2025年04月18日03时36分，Intellia Therapeutics, Inc.股票出现波动，股价大幅上涨5.03%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.95%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418033641aa2c739c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418033641aa2c739c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1861558580.USD","LU1861559042.SGD","NTLA","BK4556","BK4535","BK4585","BK4588","BK4007","LENZ"],"gpt_icon":0},{"id":"2527424952","title":"Crispr Therapeutics Ag盘中异动 早盘股价大跌5.04%报36.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527424952","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527424952?lang=zh_cn&edition=fundamental","pubTime":"2025-04-16 22:03","pubTimestamp":1744812231,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日22时03分，Crispr Therapeutics Ag股票出现波动，股价大幅下跌5.04%。截至发稿，该股报36.99美元/股，成交量23.3247万股，换手率0.27%，振幅4.03%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体跌幅为1.39%。Crispr Therapeutics Ag公司简介：CRISPR Therapeutics AG是一家基因编辑公司，专注于开发基于Crispr/Cas9的疗法。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416220351aa2c718c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416220351aa2c718c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4611","CRSP","BK4139","BK4556","LU1861558580.USD","LENZ","BK4585","LU1861559042.SGD","BK4007","BK4588"],"gpt_icon":0},{"id":"2527408246","title":"Beam Therapeutics Inc.盘中异动 快速下跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527408246","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527408246?lang=zh_cn&edition=fundamental","pubTime":"2025-04-16 21:53","pubTimestamp":1744811592,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日21时53分，Beam Therapeutics Inc.股票出现异动，股价大幅下跌5.03%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.12%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家生物技术公司，致力于基于其专有的碱基编辑技术开发一类新的精准基因药物，为患有严重疾病的患者提供终身治愈方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041621531294d7885c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041621531294d7885c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BEAM","BK4611","BK4505","BK4535","BK4556","BK4588","BK4585","BK4007"],"gpt_icon":0},{"id":"2527958244","title":"Intellia Therapeutics, Inc.盘中异动 早盘大幅下跌5.16%报6.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527958244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527958244?lang=zh_cn&edition=fundamental","pubTime":"2025-04-16 21:53","pubTimestamp":1744811581,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日21时53分，Intellia Therapeutics, Inc.股票出现异动，股价快速跳水5.16%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.12%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416215302a45b3276&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416215302a45b3276&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","NTLA","LU1861558580.USD","LU1861559042.SGD","BK4535","BK4556","BK4588","BK4585","BK4007"],"gpt_icon":1},{"id":"2527439392","title":"Editas Medicine, Inc.盘中异动 早盘大幅下挫5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527439392","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527439392?lang=zh_cn&edition=fundamental","pubTime":"2025-04-16 21:40","pubTimestamp":1744810832,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日21时40分，Editas Medicine, Inc.股票出现异动，股价急速跳水5.18%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。其相关个股中，Dermata Therapeutics Inc C/Wts 、Psyence Biomedical Ltd C/Wts 25/01/2029、Briacell Therapeutics Corp.涨幅较大，Briacell Therapeutics Corp.、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为399.65%、147.82%、43.72%，振幅较大的相关个股有天演药业、Psyence Biomedical Ltd C/Wts 25/01/2029、Phio Pharmaceuticals Corp.，振幅分别为20.62%、20.00%、18.52%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416214032aa2c7155&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416214032aa2c7155&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT","BK4139","BK4556"],"gpt_icon":0},{"id":"2527824483","title":"蓝鸟生物股价重挫10.07% 市值跌378.69万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527824483","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527824483?lang=zh_cn&edition=fundamental","pubTime":"2025-04-16 21:30","pubTimestamp":1744810225,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日21时30分，蓝鸟生物股票出现波动，股价急速下跌10.07%。截至发稿，该股报4.02美元/股，成交量3.5849万股，换手率0.37%，振幅0.49%。蓝鸟生物股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Dermata Therapeutics Inc C/Wts 、天演药业、Essa Pharma Inc.涨幅较大，Briacell Therapeutics Corp.、Pmgc Holdings Inc.、Mural Oncology Plc较为活跃，换手率分别为325.01%、143.92%、8.06%，振幅较大的相关个股有天演药业、蓝鸟生物、Pasithea Therapeutics Corp.，振幅分别为20.00%、10.07%、4.55%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416213026a6bca2fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416213026a6bca2fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4578","ADAG","BK4556","BLUE","BK4139"],"gpt_icon":0},{"id":"2527821212","title":"BUZZ-青鸟生物因艾尔米德公司未能给出具有约束力的收购要约而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2527821212","media":"路透中文","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527821212?lang=zh_cn&edition=fundamental","pubTime":"2025-04-16 20:54","pubTimestamp":1744808095,"startTime":"0","endTime":"0","summary":"** BLUE 补充说，该公司仍面临严重的贷款违约风险。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nL4S3QU0Z8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLUE","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4135","BK4556","BK4578","IE00BGHQF748.EUR","CG","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":31,"code":"91000000","status":"200"}]}}